Rare Genetic Variants and Familial Multiple Sclerosis: Insights from Whole-Exome Sequencing
Multiple sclerosis (MS) is a complex immune-mediated disease of the central nervous system characterized by inflammation, demyelination, axonal injury, and substantial clinical heterogeneity. The article, “Exome Sequencing Uncovers Genetic Drivers of Multiple Sclerosis in a Multiplex Family,” investigates a multigenerational Italian family with several affected members and asks whether rare inherited variants may help explain disease clustering beyond known common-risk loci. The authors emphasize that genome-wide association studies have identified many MS-associated loci, especially within immune-regulatory regions, but these loci do not fully explain MS heritability. This gap provides the rationale for whole-exome sequencing (WES), particularly in multiplex families where rare variants of moderate or large effect may segregate with disease.
Study Design: Whole-Exome Sequencing in a Multiplex Pedigree
The study focused on a three-generation family in which two sisters, one cousin, and the son of one affected sister had MS. The pedigree shown in Figure 1 illustrates the familial structure and highlights the affected individuals, while WES was performed on three affected family members and one unaffected brother. The sequencing achieved approximately 60× average coverage, and the authors applied a rigorous variant-filtering strategy based on quality, allele frequency, predicted functional impact, and co-segregation with disease. The workflow in Figure 2 summarizes this progressive narrowing process: from roughly 20,000–25,000 raw variants per individual to 47 rare co-segregating variants, and finally to three prioritized candidate variants.
Candidate Variants: RTN4, JAK2, and DUOX2
The three strongest candidate variants identified were RTN4 c.443C>T, p.Pro148Leu; JAK2 c.1678T>G, p.Phe560Val; and DUOX2 c.3449A>G, p.Tyr1150Cys. These variants were present in the affected sequenced individuals and absent from two healthy brothers, strengthening their candidacy within this family. Importantly, all three were classified as variants of uncertain significance, meaning that the study does not establish them as definitively pathogenic. Nevertheless, their biological relevance is compelling: RTN4 is linked to neurite outgrowth inhibition and remyelination biology, JAK2 is central to cytokine-mediated immune signaling, and DUOX2 participates in reactive oxygen species generation and oxidative stress pathways.
RTN4 and the Biology of Failed Remyelination
The RTN4 gene encodes reticulon-4, including the Nogo-A isoform, a well-known inhibitor of axonal regeneration and neural plasticity in the adult central nervous system. In MS, failure of remyelination is a major determinant of chronic disability, and molecules that inhibit axonal repair are therefore of high mechanistic interest. The p.Pro148Leu variant identified in this family lies within a proline-rich disordered region near the amino terminus of the protein, close to a domain implicated in neurite outgrowth inhibition. Although structural modeling was not feasible because of the disordered nature of this protein region, the authors note that the variant is absent from population databases and has a relatively high CADD score, suggesting potential functional relevance.
JAK2 and Immune Dysregulation in Neuroinflammation
The JAK2 variant may be especially important because Janus kinase 2 is a central component of the JAK-STAT pathway, which transduces cytokine signals involved in immune activation, inflammation, and differentiation of pathogenic T-cell subsets. In MS biology, Th1 and Th17 immune responses are highly relevant because they contribute to central nervous system inflammation and demyelination. The authors’ protein modeling suggests that the p.Phe560Val substitution may destabilize the JAK2 protein structure by disrupting molecular interactions, including a π–π stacking interaction that normally helps stabilize the kinase domain. Figure 3 visually presents this structural interpretation and indicates that the substitution may also perturb a nearby inhibitor-binding pocket, raising the possibility of altered JAK2 signaling.
DUOX2, Oxidative Stress, and Tissue Injury
The DUOX2 variant adds a third mechanistic axis to the proposed model: oxidative damage. DUOX2 belongs to the NADPH oxidase family, enzymes that generate reactive oxygen species. In the context of MS, excessive oxidative stress can damage lipids, proteins, mitochondria, oligodendrocytes, and the blood–brain barrier, thereby amplifying inflammatory injury. The p.Tyr1150Cys substitution was modeled using an AlphaFold-derived structure, and Figure 4 shows that the mutation may disrupt π–π stacking interactions and hydrogen bonds involving nearby residues. The authors interpret these changes as potentially destabilizing, although computational predictions were not entirely uniform, reinforcing the need for functional assays.
Interpretation, Limitations, and Precision-Medicine Implications
The article proposes an oligogenic model in which RTN4, JAK2, and DUOX2 variants may jointly increase MS susceptibility through convergent effects on remyelination failure, immune signaling, and oxidative stress. This interpretation is scientifically plausible but remains preliminary because the study is based on a single family, lacks replication in independent cohorts, and does not include transcriptomic, proteomic, or experimental validation data. Its main contribution is therefore hypothesis-generating: it identifies biologically meaningful variants that may guide future studies of familial MS. If validated, these findings could support a precision-medicine framework in which genetic stratification informs therapeutic strategies targeting remyelination, JAK-STAT immune signaling, and oxidative stress control.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Lintas, C., Bonora, S., Marabotti, A., Tabolacci, C., Scattoni, M. L., Capone, F., ... & Gurrieri, F. (2025). Exome Sequencing Uncovers Genetic Drivers of Multiple Sclerosis in a Multiplex Family. Genes, 16(11), 1311.
